Extranodal involvement of diffuse large B-cell lymphoma in the head and neck: An indicator of good prognosis

Thakral, 2015, Extranodal hematopoietic neoplasms and mimics in the head and neck: an update, Hum Pathol, 46, 1079, 10.1016/j.humpath.2015.05.007 Shima, 1990, Extranodal non-Hodgkin’s lymphoma of the head and neck: a clinicopathologic study in the Kyoto-Nara area of Japan, Cancer, 66, 1190, 10.1002/1097-0142(19900915)66:6<1190::AID-CNCR2820660619>3.0.CO;2-U Nathu, 1999, Non-Hodgkin’s lymphoma of the head and neck: a 30-year experience at the University of Florida, Head Neck, 21, 247, 10.1002/(SICI)1097-0347(199905)21:3<247::AID-HED10>3.0.CO;2-6 Morton, 2007, Proposed classification of lymphoid neoplasms for epidemiologic research from the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph), Blood, 110, 695, 10.1182/blood-2006-11-051672 Vega, 2005, Extranodal lymphomas of the head and neck, Ann Diagn Pathol, 9, 340, 10.1016/j.anndiagpath.2005.09.020 The International Non-Hodgkin’s Lymphoma Prognostic Factors Project, 1993, A predictive model for aggressive non-Hodgkin’s lymphoma, N Engl J Med, 329, 987, 10.1056/NEJM199309303291402 Coiffier, 2002, CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma, N Engl J Med, 346, 235, 10.1056/NEJMoa011795 Habermann, 2006, Rituximab-CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell lymphoma, J Clin Oncol, 24, 3121, 10.1200/JCO.2005.05.1003 Hui, 2010, Prognostic implications of extranodal involvement in patients with diffuse large B-cell lymphoma treated with rituximab and cyclophosphamide, doxorubicin, vincristine, and prednisone, Leuk Lymphoma, 51, 1658, 10.3109/10428194.2010.504872 Huang, 2015, Validation of an enhanced International Prognostic Index (NCCN-IPI) in an Asian cohort of patients with diffuse large B cell lymphoma, Ann Hematol, 94, 1063, 10.1007/s00277-014-2293-8 Zhou, 2014, An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era, Blood, 123, 837, 10.1182/blood-2013-09-524108 Lu, 2015, Diffuse large B-cell lymphoma: sites of extranodal involvement are a stronger prognostic indicator than number of extranodal sites in the rituximab era, Leuk Lymphoma, 56, 2047, 10.3109/10428194.2014.982636 Sanchez, 2015, Extranodal and nodal diffuse large B cell lymphoma of the head and neck: two different entities?, Ann Hematol, 94, 609, 10.1007/s00277-014-2256-0 Hans, 2004, Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray, Blood, 103, 275, 10.1182/blood-2003-05-1545 Sarkozy, 2015, Double-hit and double-protein-expression lymphomas: aggressive and refractory lymphomas, Lancet Oncol, 16, e555, 10.1016/S1470-2045(15)00005-4 He, 2016, Clinical significance of “double-hit” and “double-protein” expression in primary gastric B-cell lymphomas, J Cancer, 7, 1215, 10.7150/jca.15395 Choi, 2009, A new immunostain algorithm classifies diffuse large B-cell lymphoma into molecular subtypes with high accuracy, Clin Cancer Res, 15, 5494, 10.1158/1078-0432.CCR-09-0113 Cheson, 1999, Report of an international workshop to standardize response criteria for non-Hodgkin’s lymphomas NCI Sponsored International Working Group, J Clin Oncol, 17, 1244, 10.1200/JCO.1999.17.4.1244 Hart, 2004, Localised extranodal lymphoma of the head and neck: the Sheffield Lymphoma Group experience (1971–2000), Clin Oncol (R Coll Radiol), 16, 186, 10.1016/j.clon.2003.10.010 Etemad-Moghadam, 2010, Head and neck non-Hodgkin’s lymphoma: a 20-year demographic study of 381 cases, Int J Oral Maxillofac Surg, 39, 869, 10.1016/j.ijom.2010.03.029 Chen, 2010, Upper aerodigestive tract lymphoma in Taiwan, J Clin Pathol, 63, 888, 10.1136/jcp.2010.081927 Dojcinov, 2010, EBV positive mucocutaneous ulcer—a study of 26 cases associated with various sources of immunosuppression, Am J Surg Pathol, 34, 405, 10.1097/PAS.0b013e3181cf8622 Hart, 2014, EBV-positive mucocutaneous ulcer in organ transplant recipients: a localized indolent posttransplant lymphoproliferative disorder, Am J Surg Pathol, 38, 1522, 10.1097/PAS.0000000000000282 Gualco, 2011, Clinicopathologic and molecular features of 122 Brazilian cases of nodal and extranodal NK/T-cell lymphoma, nasal type, with EBV subtyping analysis, Am J Surg Pathol, 35, 1195, 10.1097/PAS.0b013e31821ec4b5 Ruiz, 2007, Extranodal marginal zone B-cell lymphomas of the ocular adnexa: multiparameter analysis of 34 cases including interphase molecular cytogenetics and PCR for Chlamydia psittaci, Am J Surg Pathol, 31, 792, 10.1097/01.pas.0000249445.28713.88 Petrella, 2007, Indolent CD8-positive lymphoid proliferation of the ear: a distinct primary cutaneous T-cell lymphoma?, Am J Surg Pathol, 31, 1887, 10.1097/PAS.0b013e318068b527 Carbone, 2000, Pathological features of lymphoid proliferations of the salivary glands: lymphoepithelial sialadenitis versus low-grade B-cell lymphoma of the malt type, Ann Otol Rhinol Laryngol, 109, 1170, 10.1177/000348940010901217 Attygalle, 2004, A typical marginal zone hyperplasia of mucosa-associated lymphoid tissue: a reactive condition of childhood showing immunoglobulin lambda light-chain restriction, Blood, 104, 3343, 10.1182/blood-2004-01-0385 Kalpadakis, 2008, Non-gastric extra-nodal marginal zone lymphomas—a single centre experience on 76 patients, Leuk Lymphoma, 49, 2308, 10.1080/10428190802510331 Mian, 2014, Early-stage diffuse large B cell lymphoma of the head and neck: clinico-biological characterization and 18 year follow-up of 488 patients (IELSG 23 study), Ann Hematol, 93, 221, 10.1007/s00277-013-1856-4 Coiffier, 2005, State-of-the-art therapeutics: diffuse large B-cell lymphoma, J Clin Oncol, 23, 6387, 10.1200/JCO.2005.05.015 Takahashi, 2012, Prognostic impact of extranodal involvement in diffuse large B-cell lymphoma in the rituximab era, Cancer, 118, 4166, 10.1002/cncr.27381 Hwang, 2016, A new extranodal scoring system based on the prognostically relevant extranodal sites in diffuse large B-cell lymphoma, not otherwise specified treated with chemoimmunotherapy, Ann Hematol, 95, 1249, 10.1007/s00277-016-2689-8 Olszewski, 2014, Improved survival with rituximab-based chemoimmunotherapy in older patients with extranodal diffuse large B-cell lymphoma, Leuk Res, 38, 866, 10.1016/j.leukres.2014.04.009 Benesova, 2013, The Hans algorithm failed to predict outcome in patients with diffuse large B-cell lymphoma treated with rituximab, Neoplasma, 60, 68, 10.4149/neo_2013_010 Lu, 2016, The distinct clinical features and prognosis of the CD10+MUM1+ and CD10−Bcl6−MUM1− diffuse large B-cell lymphoma, Sci Rep, 6, 20465, 10.1038/srep20465